SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 

 
FORM 6-K
 
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 of the
Securities Exchange Act of 1934
 

For the month of July, 2017

Commission File Number 1565025

 

 

AMBEV S.A.
(Exact name of registrant as specified in its charter)
 

AMBEV S.A.
(Translation of Registrant's name into English)
 

Rua Dr. Renato Paes de Barros, 1017 - 3rd Floor
04530-000 São Paulo, SP
Federative Republic of Brazil
(Address of principal executive office)
 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. 


Form 20-F ___X___ Form 40-F _______

  Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.  

Yes _______ No ___X____


 

 

INDIVIDUAL FORM

Article 11 - CVM Instruction # 358/2002

 

In June 2017:

 

( X ) the only transactions with securities and derivatives were those presented below, in compliance with Article 11 - CVM Instruction # 358/2002. (1)

 

(   ) no securities and derivatives operations took place, in compliance with Article 11 - CVM Instruction # 358/2002, with my securities and derivatives positions as follows.

 

Company Name: Ambev S.A.

Name: Ambev S.A.

CPF/CNPJ: 07.526.557/0001-00

Qualification: Outstanding Shares in Treasury

Initial Balance

Securities / Derivatives

Securities Characteristics (2)

Quantity

%

Same Class and Type

Total

Shares

Common

11,549,298

0.0735

0.0735

Transac tions in the month

Securities / Derivatives

Securities Characteristics (2)

Intermediary

Operation

Day

Quantity

Price

Volume (R$) (3)

Shares

Common

Direct with the Company

Conversion in ADRs

01

491,775

0.0000

0.00

 

 

 

Total Conversion ADRs (Out)

 

491,775

 

0.00

Shares

Common

Direct with the Company

Exerc Options

06

20,350

1.25284

25,495.29

Shares

Common

Direct with the Company

Exerc Options

06

53,775

1.45648

78,322.21

Shares

Common

Direct with the Company

Exerc Options

13

71,700

1.45648

104,429.62

Shares

Common

Direct with the Company

Exerc Options

13

46,000

3.28096

150,924.16

Shares

Common

Direct with the Company

Exerc Options

13

45,175

9.35960

422,819.93

Shares

Common

Direct with the Company

Exerc Options

13

38,080

11.97200

455,893.76

Shares

Common

Direct with the Company

Exerc Options

28

124,717

9.35960

1.167,301.23

Shares

Common

Direct with the Company

Exerc Options

28

81,753

11.97200

978,746.92

Shares

Common

Direct with the Company

Exerc Options

29

161,750

1.09284

176,766.87

Shares

Common

Direct with the Company

Exerc Options

29

144,375

1.29648

187,179.30

Shares

Common

Direct with the Company

Exerc Options

29

93,400

3.12096

291,497.66

 

 

 

Total Sell

 

881,075

 

4,039,376.95

 

 

 

 

 

 

 

 

Shares

Common

Direct with the Company

Plan of Shares Acquisition

05

38,582

18.91

729,585.62

Shares

Common

Direct with the Company

Plan of Shares Acquisition

08

3,100

18.53

57,443.00

Shares

Common

Direct with the Company

Plan of Shares Acquisition

13

61,668

18.39

1,134,074.52

Shares

Common

Direct with the Company

Plan of Shares Acquisition

27

5,933

18.29

108,514.57

Shares

Common

Direct with the Company

Plan of Shares Acquisition

28

117,271

18.30

2,146,059.30

Shares

Common

Direct with the Company

Plan of Shares Acquisition

29

35,915

18.25

655,448.75

 

 

 

Total Buy

 

262,469

 

4,831,125.76

Final Balance

Securities / Derivatives

Securities Characteristics (2)

Quantity

%

Same Class and Type

Total

Shares

Common

10,438,917

0.0664

0.0664

                       

 


 

 

 

(1)       When filling in the form, delete the lines that do not have any information. If there is no acquisition/change in the position of any person in relation to Article 11 - CVM Instruction # 358/2002, send a statement with that information.

 

(2)       Issue/Series, convertibility, simple, term, guaranties, type/class, among others.

 

(3)       Quantity multiplied by price .

 


 

 

INDIVIDUAL FORM

Article 11 - CVM Instruction # 358/2002

 

In June 2017:

 

( X ) the only transactions with securities and derivatives were those presented below, in compliance with Article 11 - CVM Instruction # 358/2002. (1)

 

(  ) no securities and derivatives operations took place, in compliance with Article 11 - CVM Instruction # 358/2002, with my securities and derivatives positions as follows.

 

Company Name: Ambev S.A.

Name: Ambev S.A.

CPF/CNPJ: 07.526.557/0001-00

Qualification: Outstanding Shares in Treasury

Initial Balance

Securities / Derivatives

Securities Characteristics (2)

Quantity

%

Same Class and Type

Total

ADR (*)

Common

0

0.0000

0.0000

Transac tions in the month

Securities / Derivatives

Securities Characteristics (2)

Intermediary

Operation

Day

Quantity

Price USD

Volume (USD) (3)

ADR (*)

Common

Direct with the Company

Conversion in ADRs

01

491,775

0.0000

0.00

 

 

 

Total Conversion ADRs (In)

 

491,775

 

 

ADR (*)

Common

Direct with the Company

Exerc Options

01

112,950

1.296383

146,426.46

ADR (*)

Common

Direct with the Company

Exerc Options

01

105,725

0.000000

0.00

ADR (*)

Common

Direct with the Company

Exerc Options

01

184,425

1.178444

217,334.53

ADR (*)

Common

Direct with the Company

Exerc Options

01

88,675

2.282458

202,396.96

 

 

 

Total Sell

 

491,775

 

566,157.95

 

 

 

 

 

 

 

 

Final Balance

Securities / Derivatives

Securities Characteristics (2)

Quantity

%

Same Class and Type

Total

ADR (*)

Common

0

0.0000

0.0000

                       

 

(1)       When filling in the form, delete the lines that do not have any information. If there is no acquisition/change in the position of any person in relation to Article 11 - CVM Instruction # 358/2002, send a statement with that information.

 

(2)       Issue/Series, convertibility, simple, term, guaranties, type/class, among others.

 

(3)       Quantity multiplied by price .

 

(*)    Each ADR is equivalent to 1 (one) share.

 

 

 

 


 

 

INDIVIDUAL FORM

Article 11 - CVM Instruction # 358/2002

 

In June 2017:

 

( X ) the only transactions with securities and derivatives were those presented below, in compliance with Article 11 - CVM Instruction # 358/2002. (1)

 

(  ) no securities and derivatives operations took place, in compliance with Article 11 - CVM Instruction # 358/2002, with my securities and derivatives positions as follows.

 

Subsidiary Name: Ambev Luxembourg S.À.R.L.

Qualification: Position – Total Return Swap

Transac tions in the month

Securities / Derivatives

Securities Characteristics (2)

Intermediary

Operation

Day (**)

Quantity (***)

Price USD

Volume (USD) (3)

Swap

ADR (*)

N/A

Total Return Swap Conclusion

19

18,282,025

5.46985

100,000,000.00

 

 

 

Total operation

 

18,282,025

 

100,000,000.00

 

(1)      When filling in the form, delete the lines that do not have any information. If there is no acquisition/change in the position of any person in relation to Article 11 - CVM Instruction # 358/2002, send a statement with that information.

 

(2)       Issue/Series, convertibility, simple, term, guaranties, type/class, among others.

 

(3)       Quantity multiplied by price .

 

 

(*) Each ADR is equivalent to 1 (one) share.

 

(**) In accordance with the Circular Letter/CVM/SEP/Nº07/2017, date information of the total return swap conclusion and not the date of the financial settlement of the transaction.

 

(***) The reported quantity is not actually related to a purchase or sale, but an economic exposure arising from the conclusion of a swap agreement on a consolidated basis, in accordance with the Circular Letter/CVM/SEP/Nº07/2017.

 

 

 

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
Date: July 10, 2017

 

     
 
AMBEV S.A.
     
 
By: 
/s/ Ricardo Rittes de Oliveira Silva
 
Ricardo Rittes de Oliveira Silva
Chief Financial and Investor Relations Officer
 
 
 
 

 

 

Ambev (NYSE:ABEV)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Ambev Charts.
Ambev (NYSE:ABEV)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Ambev Charts.